Schrodinger (NASDAQ:SDGR – Get Free Report) and Information Analysis (OTCMKTS:IAIC – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.
Risk & Volatility
Schrodinger has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Comparatively, Information Analysis has a beta of 3.25, suggesting that its stock price is 225% more volatile than the S&P 500.
Earnings & Valuation
This table compares Schrodinger and Information Analysis”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Schrodinger | $255.87 million | 5.68 | -$103.26 million | ($0.74) | -26.62 |
| Information Analysis | $13.90 million | 0.00 | $410,000.00 | $0.04 | N/A |
Information Analysis has lower revenue, but higher earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Information Analysis, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings for Schrodinger and Information Analysis, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Schrodinger | 1 | 3 | 3 | 0 | 2.29 |
| Information Analysis | 0 | 0 | 0 | 0 | 0.00 |
Schrodinger currently has a consensus price target of $20.50, suggesting a potential upside of 4.06%. Given Schrodinger’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Schrodinger is more favorable than Information Analysis.
Profitability
This table compares Schrodinger and Information Analysis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Schrodinger | -20.98% | -16.37% | -8.19% |
| Information Analysis | 3.72% | 18.48% | 9.33% |
Institutional and Insider Ownership
79.0% of Schrodinger shares are held by institutional investors. 10.1% of Schrodinger shares are held by company insiders. Comparatively, 23.8% of Information Analysis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Information Analysis beats Schrodinger on 8 of the 13 factors compared between the two stocks.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
About Information Analysis
Information Analysis, Inc. provides information technology services. The firm engages in the business of modernizing client information systems, developing and maintaining information technology systems, and performing consulting services to government and commercial organizations. It specializes in legacy systems modernization, ebusiness solutions, enterprise portals, system migration and re-hosting services, and enterprise application integration. The company was founded by Sandor Rosenberg in 1979 and is headquartered in Fairfax, VA.
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
